News Gilead Sciences Announces Pricing for Remdesivir COVID-19 Treatment The cost of Remdesivir treatment is set at around $3,120. Gilead Sciences, a biopharmaceutical company, revealed today its pricing strategy for remdesivir, a newly... Mike BrookmanJune 29, 2020